|
1
|
Jemal A, Bray F, Center MM, Ferley J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
American Cancer Society, . Cervical
cancer: What are the key statistics about cervical cancer?
http://www.cancer.org/cancer/cervicalcancer/detailedguide/cervical-cancer-key-statisticsLast
revised. January 31–2014 June 9–2014
|
|
3
|
Cancer.net, . Cervical cancer: Statistics.
http://www.cancer.net/cancer-types/cervical-cancer/statisticsLast
reviewed. April;2014 June 9–2014
|
|
4
|
Fidler IJ: Molecular biology of cancer:
Invasion and metastasisCancer Principles and Practice of Oncology.
DeVita VT Jr, Hellman S and Rosenberg SA: 5th. Lippincott-Raven;
Philadelphia, PA: pp. 135–152. 1997
|
|
5
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Folkman J: Role of angiogenesis in tumor
growth and metastasis. Semin Oncol. 29:(Suppl 16). 15–18. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chambers AF and Matrisian LM: Changing
views on the role of matrix metalloproteinases in metastasis. J
Natl Cancer Inst. 89:1260–1270. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kleiner DE and Stetler-Stevenson WG:
Matrix metalloproteinases and metastasis. Cancer Chemother
Pharmacol. 43:(Suppl). 42–51. 1999. View Article : Google Scholar
|
|
9
|
Yurchenko PD and Schitny JC: Molecular
architecture of basement membranes. FASEB J. 4:1577–1590.
1990.PubMed/NCBI
|
|
10
|
Barsky SH, Siegel GP, Jannotta F and
Liotta LA: Loss of basement membrane components by invasive tumors
but not by their benign counterparts. Lab Invest. 49:140–147.
1983.PubMed/NCBI
|
|
11
|
Liotta LA, Tryggvason K, Garbisa S, Hart
I, Foltz CM and Shafie S: Metastatic potential correlates with
enzymatic degradation of basement membrane collagen. Nature.
284:67–68. 1980. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Stetler-Stevenson WG: The role of matrix
metalloproteinases in tumor invasion, metastasis and angiogenesis.
Surg Oncol Clin N Am. 10:383–392. 2001.PubMed/NCBI
|
|
13
|
Stetler-Stevenson WG: Type IV collagenases
in tumor invasion and metastasis. Cancer Metastasis Rev. 9:289–303.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Davidson B, Goldberg I, Koplovic J,
Lerner-Geva L, Gottlieb WH, Weiss B, Ben-Baruch G and Reich R:
Expression of matrix metalloproteinase-9 in squamous cell carcinoma
of the uterine cervix - clinicopathologic study using
immunohistochemistry and mRNA in situ hybridization. Gynecol
Oncol. 72:380–386. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rath M and Pauling L: Plasmin-induced
proteolysis and the role of apoprotein (a), lysine and synthetic
analogs. J Orthomol Med. 7:17–23. 1992.
|
|
16
|
Andreasen PA, Kjøller L, Christensen L and
Duffy MJ: The urokinase-type plasminogen activator system in cancer
metastasis: A review. Int J Cancer. 72:1–22. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Niedzwiecki A, Roomi MW, Kalinovsky T and
Rath M: Micronutrient synergy - a new tool in effective control of
metastasis and other key mechanisms of cancer. Cancer Metastasis
Rev. 29:529–543. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Roomi MW, Kalinovsky T, Rath M and
Niedzwiecki A: Modulation of u-PA, MMPs and their inhibitors by a
novel nutrient mixture in human female cancer cell lines. Oncol
Rep. 28:768–776. 2012.PubMed/NCBI
|
|
19
|
Roomi MW, Ivanov V, Kalinovsky T,
Niedzwiecki A and Rath M: Suppression of human cervical cancer cell
lines Hela and DoTc2 4510 by a mixture of lysine, proline, ascorbic
acid and green tea extract. Int J Gynecol Cancer. 16:1241–1247.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cameron E, Pauling L and Leibovitz B:
Ascorbic acid and cancer: A review. Cancer Res. 39:663–681.
1979.PubMed/NCBI
|
|
21
|
Almholt K, Juncker-Jensen A, Laerum OD,
Danø K, Johnsen M, Lund LR and Rømer J: Metastasis is strongly
reduced by the matrix metalloproteinase inhibitor Galardin in the
MMTV-PymT transgenic breast cancer model. Mol Cancer Ther.
7:2758–2767. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pankov R and Yamada KM: Fibronectin at a
glance. J Cell Sci. 115:3861–3863. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ruoslahti E: Fibronectin and its integrin
receptors in cancer. Adv Cancer Res. 76:1–20. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Timpl R, Rohde H, Robey PG, Rennard SI,
Foidart JM and Martin GR: Laminin - a glycoprotein from basement
membranes. J Biol Chem. 254:9933–9937. 1979.PubMed/NCBI
|
|
25
|
Sun Z, Chen YH, Wang P, Zhang J, Gurewich
V, Zhang P and Liu JN: The blockage of high-affinity lysine binding
sites of plasminogen by EACA significantly inhibits
prourokinase-induced plasminogen activation. Biochem Biophys Acta.
1596:182–192. 2002.PubMed/NCBI
|
|
26
|
Valcic S, Timmermann BN, Alberts DS,
Wachter GA, Krutzsch M, Wymer J and Guillén JM: Inhibitory effect
of six green tea catechins and caffeine on the growth of four
selected human tumor cell lines. Anticancer Drugs. 7:461–468. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mukhtar H and Ahmed N: Tea polyphenols:
Prevention of cancer and optimizing health. Am J Clin Nutr. 71:(Sul
6). 1698S–1702S. 2000.PubMed/NCBI
|
|
28
|
Yang CY, Liao J, Kim K, Yurtow EJ and Yang
CS: Inhibition of growth and induction of apoptosis in human cancer
cell lines by tea polyphenols. Carcinogenesis. 19:611–616. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Taniguchi S, Fujiki H, Kobayashi H, Go H,
Miyado K, Sadano H and Shimikawa R: Effect of (−) epigallocatechin
gallate, the main constituent of green tea, on lung metastasis with
mouse B16 melanoma cell lines. Cancer Lett. 65:51–54. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hara Y: Green Tea - Health Benefits and
Applications. Marcel Dekker; New York, NY: 2001, View Article : Google Scholar
|
|
31
|
Kawakami S, Kageyama Y, Fujii Y, Kihara K
and Oshima H: Inhibitory effects of N-acetyl cysteine on invasion
and MMP-9 production of T24 human bladder cancer cells. Anticancer
Res. 21:213–219. 2001.PubMed/NCBI
|
|
32
|
Morini M, Cai T, Aluigi MG, Noonan DM,
Masiello L, De Floro S, D'Agostinin F, Albini A and Fassima G: The
role of the thiol N-acetyl cysteine in the prevention of tumor
invasion and angiogenesis. Int J Biol Markers. 14:268–271.
1999.PubMed/NCBI
|
|
33
|
Yoon SO, Kim MM and Chung AS: Inhibitory
effects of selenite on invasion of HT 1080 tumor cells. J Biol
Chem. 276:20085–20092. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cha J, Roomi MW, Ivanov V, Kalinovsky T,
Niedzwiecki A and Rath M: Ascorbate supplementation inhibits growth
and metastasis of B16FO melanoma and 4T1 breast cancer cells in
vitamin C deficient mice. Int J Oncol. 42:55–64. 2013.PubMed/NCBI
|
|
35
|
Naidu KA, Karl RC, Naidu KA and Coppola D:
Antiproliferative and proapoptotic effect of ascorbyl stearate in
human pancreatic cancer cells: Association with decreased
expression of insulin-like growth factor 1 receptor. Dig Dis Sci.
48:230–237. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Anthony HM and Schorah CJ: Severe
hypovitaminosis C in lung-cancer patients: The utilization of
vitamin C in surgical repair and lymphocyte-related host
resistance. Br J Cancer. 46:354–367. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Maramag C, Menon M, Balaji KC, Reddy PG
and Laxmanan S: Effect of vitamin C on prostate cancer cells in
vitro: effect on cell number, viability and DNA synthesis.
Prostate. 32:188–195. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Koh WS, Lee SJ, Lee H, Park C, Park MH,
Kim WS, Yoon SS, Park K, Hong SI, Chung MH and Park CH:
Differential effects and transport kinetics of ascorbate
derivatives in leukemic cell lines. Anticancer Res. 8:2487–2493.
1998.
|
|
39
|
Chen Q, Espey MG, Krishna MC, Mitchell JB,
Corpe CP, Buettner GR, Shacter E and Levine M: Pharmacologic
ascorbic acid concentrations selectively kill cancer cells: Action
as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl
Acad Sci USA. 102:13604–13609. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Núñez Martín C and Ortiz de Apodaca y Ruiz
A: Ascorbic acid in the plasma and blood cells of women with breast
cancer. The effect of consumption of food with an elevated content
of this vitamin. Nutr Hosp. 10:368–372. 1995.PubMed/NCBI
|
|
41
|
Kurbacher CM, Wagner U, Kolster B,
Andreotti PE, Krebs D and Bruckner HW: Ascorbic acid (vitamin C)
improves the antineoplastic activity of doxorubicin, cisplatin and
paclitaxel in human breast carcinoma cells in vitro. Cancer Lett.
103:183–189. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cooke JP and Dzau VJ: Nitric oxide
synthase: Role in the genesis of vascular disease. Annu Rev Med.
48:489–509. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Roomi MW, Ivanov V, Netke S, Niedzwiecki A
and Rath M: Serum markers of the liver, heart and kidney and lipid
profile and histopathology in ODS rats treated with nutrient
synergy. J Am Coll Nutr. 22:4772003.
|
